RPG Life Sciences Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
- June 19, 2026
- Posted by: Kunal Singla
- Category: News
RPG Life Sciences (NSE:RPGLIFE) CMP: Rs 2,286.6 (2026). 52W High: Rs 2,725. 52W Low: Rs 1,731. MCap: Rs 3,778 Cr. P/E: 33.6. Sector: Pharmaceuticals and Healthcare. JM Financial: Buy Rs 2738. ICICI…
The RPG Life Sciences stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any RPG Life Sciences share price prediction as one data point and not as a guarantee of future performance.
This article reviews every dimension of the RPG Life Sciences stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for RPG Life Sciences Stock in 2026
Analyst consensus on the RPG Life Sciences stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.
| Brokerage | Rating | RPG Life Sciences Stock Prediction (Rs) | Updated |
|---|---|---|---|
| JM Financial | Buy | Rs 2738 | 2026 |
| ICICI Securities | Neutral | Rs 2524 | 2026 |
| Analyst Consensus | — | Rs 2631 | 2026 |
The analyst target range for RPG Life Sciences reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the RPG Life Sciences stock forecast from the current price of Rs 2,286.6 may or may not be realised by end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
RPG Life Sciences Company Overview
RPG Life Sciences is a significant player in India’s pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The RPG Life Sciences stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk.
| Metric | Value |
|---|---|
| NSE Ticker | RPGLIFE |
| Sector | Pharmaceuticals and Healthcare |
| CMP | Rs 2,286.6 (2026) |
| 52 Week High | Rs 2,725 |
| 52 Week Low | Rs 1,731 |
| Market Cap | Rs 3,778 Cr |
| P/E Ratio | 33.6 |
| RPG Life Sciences Stock Prediction Consensus (12M) | Rs 2631 |
RPG Life Sciences Stock Prediction by Time Horizon
Analysts split the RPG Life Sciences share price prediction across time frames as near-term drivers differ materially from the long-term view.
Short-Term RPG Life Sciences Stock Prediction
The near-term RPG Life Sciences stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 2,286.6 are being watched closely. A short-term RPG Life Sciences share price prediction carries the most uncertainty of any time horizon.
12-Month RPG Life Sciences Stock Prediction
JM Financial targets Rs 2738 (Buy) and ICICI Securities targets Rs 2524 (Neutral). Most desks refresh their RPG Life Sciences stock forecast within two to four weeks of each quarterly earnings print. The RPG Life Sciences share price prediction should be verified against the most recent analyst reports.
Long-Term RPG Life Sciences Stock Prediction
The long-term outlook for RPG Life Sciences is built on assumptions about demand recovery, margin expansion and revenue diversification in the Pharmaceuticals and Healthcare sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.
RPG Life Sciences Stock Forecast: Key Factors
The following four factors appear consistently in analyst research on RPG Life Sciences and are the primary inputs into the bull and bear case scenarios.
US Generic Revenue
US generics revenue is the most watched metric in the RPG Life Sciences stock forecast. USFDA approval timelines and price erosion rates directly affect the RPG Life Sciences share price prediction from most research desks.
Domestic Formulations Growth
Domestic formulation growth provides a stable base that supports the RPG Life Sciences stock prediction even when export growth faces headwinds.
R&D Pipeline
The depth and commercialization pace of the R&D pipeline is a key variable in the long-term RPG Life Sciences share price prediction. New product approvals are cited as catalysts for the RPG Life Sciences stock prediction.
EBITDA Margin
Sustained EBITDA margin expansion is typically the basis for the bullish RPG Life Sciences stock forecast. Margin recovery strengthens the RPG Life Sciences share price prediction from most research desks.
RPG Life Sciences Stock Prediction: Bull and Bear Scenarios
| Scenario | RPG Life Sciences Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 2738 | Strong execution, margin improvement, favourable macro and sector re-rating |
| Base Case | Rs 2631 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 1731 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case RPG Life Sciences stock forecast of Rs 2738 assumes most positive variables converge. The base case of Rs 2631 is the analyst consensus and may or may not be achieved.
How Analysts Are Reading the RPG Life Sciences Stock Story
Analyst reviews of the RPG Life Sciences share price prediction highlight the company’s core strengths in Pharmaceuticals and Healthcare alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for RPG Life Sciences is built on real business strengths set against real risks.
Key Risks to the RPG Life Sciences Stock Prediction
USFDA Regulatory Risk
Import alerts and warning letters from the USFDA are the most significant risks to the RPG Life Sciences stock prediction. A facility closure would force an immediate sharp revision to the RPG Life Sciences share price prediction.
Price Erosion in the US
Pricing pressure in US generics compresses the revenue per product and affects the RPG Life Sciences stock forecast. Aggressive price erosion pushes the RPG Life Sciences share price prediction toward the bear case.
R&D Execution Risk
Delays in clinical trials or approval failures affect the RPG Life Sciences stock prediction. The RPG Life Sciences share price prediction is particularly sensitive to key pipeline asset announcements.
Currency Risk
A strengthening rupee against the dollar reduces export realisation and affects the RPG Life Sciences stock forecast. Currency risk is embedded in conservative RPG Life Sciences share price prediction models.
How to Monitor the RPG Life Sciences Stock Forecast
Track the RPG Life Sciences share price prediction consensus quarterly. After every earnings release, most brokerages revise their RPG Life Sciences stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on RPG Life Sciences is improving or deteriorating.
Compare the current price of Rs 2,286.6 with the analyst target range of Rs 2738 to Rs 2524. A wide target band reflects genuine uncertainty on RPG Life Sciences, so position size should reflect that range rather than the midpoint alone.
Review the RPG Life Sciences share price prediction every quarter against key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.
Check Live RPG Life Sciences Fundamentals on the Univest Screener
Conclusion
The RPG Life Sciences stock prediction for 2026 reflects the analyst community’s assessment of RPG Life Sciences’s competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 2738 while ICICI Securities has a Neutral rating with a target of Rs 2524, giving an analyst consensus of Rs 2631.
The RPG Life Sciences stock forecast is set against near-term risks that make the RPG Life Sciences share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the RPG Life Sciences share price target changes over time is more valuable than relying on any single estimate.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for RPG Life Sciences in real time.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on RPG Life Sciences Stock Prediction 2026
What is the RPG Life Sciences stock prediction for 2026?
Ans. The RPG Life Sciences stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 2631. All estimates may or may not be achieved.
Is the RPG Life Sciences stock prediction bullish or bearish?
Ans. JM Financial has a Buy rating with target Rs 2738. ICICI Securities has a Neutral rating with target Rs 2524. The RPG Life Sciences stock forecast reflects genuine analyst diversity of opinion.
What is the RPG Life Sciences share price prediction based on fundamentals?
Ans. The RPG Life Sciences share price prediction rests on the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking RPG Life Sciences closely cite these as the primary drivers of the 2026 outlook.
What is the long-term RPG Life Sciences stock prediction?
Ans. The long-term outlook assumes RPG Life Sciences sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 2631 is the nearest reliable anchor point.
What are the key risks to the RPG Life Sciences stock prediction?
Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for RPG Life Sciences should be read alongside its risk assumptions.
What does the RPG Life Sciences stock forecast say for 2026?
Ans. JM Financial: Buy target Rs 2738. ICICI Securities: Neutral target Rs 2524. These RPG Life Sciences share price prediction estimates may or may not prove accurate.
Where can I track the latest RPG Life Sciences stock prediction?
Ans. Track the latest analyst targets and price movements for RPG Life Sciences on the NSE and BSE websites and on the Univest app and screener for live data.
